JMP Securities Maintains Orthofix Medical(OFIX.US) With Hold Rating
Orthofix to Participate in Upcoming Investor Conferences
Orthofix Medical Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results and Entered Into a New-credit Agreement Worth up to $275 Million. Additionally, Stifel Upgraded the Stock From Hold to Buy and Raised Its...
Stifel Maintains Orthofix Medical(OFIX.US) With Buy Rating, Maintains Target Price $24
Roth MKM Maintains Orthofix Medical(OFIX.US) With Buy Rating, Raises Target Price to $22
Lowe's To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Friday
Orthofix Medical Analyst Ratings
Orthofix Medical Inc (OFIX) Q3 2024 Earnings Call Highlights: Strong Growth in US Spine ...
Stifel Upgrades Orthofix Medical(OFIX.US) to Buy Rating, Raises Target Price to $24
Orthofix GAAP EPS of -$0.71 Misses by $0.37, Revenue of $196.6M In-line
Orthofix Medical | 10-Q: Q3 2024 Earnings Report
Orthofix Medical | 8-K: Orthofix Reports Third Quarter 2024 Results, Reiterates Full-Year 2024 Financial Guidance, and Introduces New Three-Year Financial Targets
Orthofix Medical Affirms FY2024 Sales Guidance From $795.00M-800.00M to $795.00M-800.00M
Express News | Orthofix Medical: Outlook 6% to 7% Net Sales Cagr From 2025 Through 2027
Earnings Flash (OFIX) ORTHOFIX MEDICAL Posts Q3 Revenue $196.6M
Press Release: Orthofix Reports Third Quarter 2024 Results, Reiterates Full-Year 2024 Financial Guidance, and Introduces New Three-Year Financial Targets
Orthofix Announces New Term Loan
Express News | Orthofix Medical Q3 Gross Margin 68.7%
Express News | Orthofix Medical Q3 Adjusted Ebitda USD 19.2 Million Vs. IBES Estimate USD 17.4 Million
Earnings Preview: OFIX to Report Financial Results Pre-market on November 07
$Orthofix Medical(OFIX.US)$ is scheduled to release its financial results pre-market on November 07 ET. Earnings PreviewAnalysts estimate $Orthofix Medical(OFIX.US)$ to post revenue of USD196.52M
No Data
No Data